Rovi stock costs EUR 58.50 ahead of November results date
Published on 10/16/2026 at 10:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSRevenue and reporting dates
- Rovi scheduled its first nine months 2026 results for November 5, 2026.
- First-half revenue rose 13.2 percent while gross margin expanded by 6.5 percentage points.
- Rovi stock trades at EUR 58.50 at 10:02 a.m. CEST at Lang & Schwarz on October 16, 2026.
Rovi (ISIN ES0157261019) was trading at EUR 58.50 at Lang & Schwarz on October 16, 2026, at 10:02 a.m. CEST. The next scheduled company milestone is the release of first nine months 2026 financial results on November 5, according to Rovi.
November report sets the next test
The November release will extend a reporting sequence that began with first-quarter results on May 6, 2026. Rovi reported total revenue of EUR 154.70 million for the first three months of 2026, while its gross margin expanded by 3.8 percentage points, according to Rovi.
On July 23, 2026, the company said first-half 2026 total revenue growth reached 13.2 percent and gross margin expansion reached 6.5 percentage points. Those figures provide the clearest operating benchmark for the November update, because the next report will show whether the first-half pace continued into the third quarter.
What does the next report mean?
The key question is whether revenue growth remains strong enough to support further margin expansion. Rovi's first-half figures combine a 13.2 percent increase in total revenue with a 6.5 percentage point improvement in gross margin, making both measures central to the next release.
Three dated Rovi milestones
On May 6, 2026, Rovi reported EUR 154.70 million of first-quarter revenue. On July 23, 2026, it reported 13.2 percent total revenue growth for the first half and 6.5 percentage points of gross margin expansion. On October 16, 2026, the stock was trading at EUR 58.50 at Lang & Schwarz at 10:02 a.m. CEST.
Dates for investors
Rovi's investor calendar lists November 5, 2026, for the first nine months 2026 financial results, according to Rovi.
Stock valuation and operating context
The stock's market capitalization was EUR 3.0 billion as of October 16, 2026. Its 52-week range was EUR 53.10 to EUR 86.70 on the same date, placing the Lang & Schwarz quote inside that range. Rovi is listed on BME and belongs to the IBEX 35, according to Bolsamania.
Price holds the investor lens
For investors, the November report offers a defined checkpoint for judging whether the first-half operating improvement carried into the third quarter. The price was EUR 58.50 at Lang & Schwarz on October 16, 2026, at 10:02 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Rovi stock.
Rovi stock facts
- Company: Laboratorios Farmaceuticos Rovi, S.A.
- ISIN: ES0157261019
- Ticker: ROVI
- Primary exchange: BME
- Price Lang & Schwarz (as of October 16, 2026, 10:02 a.m. CEST): EUR 58.50
- Market capitalization: EUR 3.0 billion (as of October 16, 2026)
- 52-week range: EUR 53.10-EUR 86.70 (as of October 16, 2026)
- Index membership: IBEX 35
- Next earnings date: November 5, 2026
Market context: Market report IBEX 35.
